Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...

The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path.

Makary pointed to three bottlenecks: hospital contracting; ethical reviews and approvals; and the Investigational New Drug ...

It takes a long time, many different steps, and considerable cost, before a new drug can be approved for use as a medicine. One could be forgiven for thinking that, since billions of people across the ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...

A surprising lab discovery reveals a light-powered way to tweak complex drugs faster, cleaner, and later in development.

Kivo reports that the journey of prescription drugs involves extensive research, clinical trials, regulatory reviews, and ...

Agentic AI could reshape drug development. In this interview, Dr. Claudio D’Ambrosio discusses how agentic AI can identify novel drug compounds, improve trial design, and reduce operational ...

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.